Pathstone Family Office, LLC Amicus Therapeutics, Inc. Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
A detailed history of Pathstone Family Office, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 103,177 shares of FOLD stock, worth $970,895. This represents 0.01% of its overall portfolio holdings.
Number of Shares
103,177
Previous 102,888
0.28%
Holding current value
$970,895
Previous $1.29 Million
2.94%
% of portfolio
0.01%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
314MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$271 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$264 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$229 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$226 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$218 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.64B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...